Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs:: HELP NSAIDs study

被引:290
作者
Hawkey, CJ [1 ]
Tulassay, Z
Szczepanski, L
van Rensburg, CJ
Filipowicz-Sosnowska, A
Lanas, A
Wason, CM
Peacock, RA
Gillon, KRW
机构
[1] Univ Nottingham Hosp, Div Gastroenterol, Nottingham NG7 2UH, England
[2] Belgyogyaszati Klin, Budapest, Hungary
[3] Sch Med, Dept Rheumatol, Lublin, Poland
[4] Tygerberg Hosp, Dept Gastroenterol, Tygerberg, South Africa
[5] Inst Rheumatol, Warsaw, Poland
[6] Hosp Clin, Serv Digest, Zaragoza, Spain
[7] Astra Clin Res Unit, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1016/S0140-6736(98)04206-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The effect of Helicobacter pylori in patients receiving non-steroidal anti-inflammatory drugs (NSAIDs) is unclear. We investigated the effects of H pylori eradication in patients with current or previous peptic ulceration, dyspepsia, or both who continued to use NSAIDs. Methods 285 patients were randomly assigned omeprazole 20 mg, amoxycillin 1000 mg, and clarithromycin 500 mg, twice daily (n=142, H pylori eradication treatment), or omeprazole with placebo antibiotics (n=143, controls) for 1 week. All patients received omeprazole 20 mg once daily for 3 weeks until endoscopy, and, if the ulcer was not healed, 40 mg once daily until repeat endoscopy at 8 weeks. Ulcer-free patients with mild dyspepsia continued NSAIDs but not antiulcer treatment. We investigated ulcers with endoscopy at 1, 3, and 6 months and with carbon-13-labelled urea breath test at 3 months. Findings The estimated probability of being ulcer-free at 6 months was 0.56 (95% CI 0.47-0.65) on eradication treatment and 0.53 (0.44-0.62) on on control treatment (p=0.80). Time to treatment failure did not differ between groups for ulcers or dyspepsia alone, per-protocol analysis, or final H pylori status. 66% (58-74) of the eradication group compared with 14% (8-20) of the control group had a final negative H pylori result (p<0.001). Fewer baseline gastric ulcers healed among eradication-treatment patients than among controls (72 vs 100% at 8 weeks, p=0.006). Interpretation H pylori eradication in long-term users of NSAIDs with past or current peptic ulcer or troublesome dyspepsia led to impaired healing of gastric ulcers and did not affect the rate of peptic ulcers or dyspepsia over 6 months. Interpretation H pylori eradication in long-term users of NSAIDs with past or current peptic ulcer or troublesome dyspepsia led to impaired healing of gastric ulcers and did not affect the rate of peptic ulcers or dyspepsia over 6 months.
引用
收藏
页码:1016 / 1021
页数:6
相关论文
共 33 条
  • [1] Aalykke C, 1997, GASTROENTEROLOGY, V112, pA51
  • [2] BELL GD, 1993, Q J MED, V86, P375
  • [3] CAMPYLOBACTER-LIKE ORGANISMS, NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND GASTRIC-LESIONS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    CASELLI, M
    PAZZI, P
    LACORTE, R
    ALEOTTI, A
    TREVISANI, L
    STABELLINI, G
    [J]. DIGESTION, 1989, 44 (02) : 101 - 104
  • [4] Eradication of H-pylori versus maintenance acid suppression to prevent recurrent ulcer hemorrhage in high risk NSAID users:: A prospective randomized study.
    Chan, FKL
    Sung, JY
    Suen, R
    Lee, YT
    Leung, WK
    Leung, VKS
    Wu, JCY
    Chung, CS
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A87 - A87
  • [5] Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
    Chan, FKL
    Sung, JJY
    Chung, SCS
    To, KF
    Yung, MY
    Leung, VKS
    Lee, YT
    Chan, CSY
    Li, EKM
    Woo, J
    [J]. LANCET, 1997, 350 (9083) : 975 - 979
  • [6] Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs
    Cullen, DJE
    Hawkey, GM
    Greenwood, DC
    Humphreys, H
    Shepherd, V
    Logan, RFA
    Hawkey, CJ
    [J]. GUT, 1997, 41 (04) : 459 - 462
  • [7] Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy - A Nordic multicentre study
    Ekstrom, P
    Carling, L
    Wetterhus, S
    Wingren, PE
    AnkerHansen, O
    Lundegardh, G
    Thorhallsson, E
    Unge, P
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (08) : 753 - 758
  • [8] FACTORS INFLUENCING THE ERADICATION OF HELICOBACTER-PYLORI WITH TRIPLE THERAPY
    GRAHAM, DY
    LEW, GM
    MALATY, HM
    EVANS, DG
    EVANS, DJ
    KLEIN, PD
    ALPERT, LC
    GENTA, RM
    [J]. GASTROENTEROLOGY, 1992, 102 (02) : 493 - 496
  • [9] TREATMENT OF HELICOBACTER-PYLORI REDUCES THE RATE OF REBLEEDING IN PEPTIC-ULCER DISEASE
    GRAHAM, DY
    HEPPS, KS
    RAMIREZ, FC
    LEW, GM
    SAEED, ZA
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (11) : 939 - 942
  • [10] Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
    Hawkey, CJ
    Karrasch, JA
    Szczepanski, L
    Walker, DG
    Barkun, A
    Swannell, AJ
    Yeomans, ND
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) : 727 - 734